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Context: Kallmann Syndrome (KS), is a rare, genetically heterogeneous Mendelian 
disorder in which structural defects in KS patients have helped define the genetic 
architecture of GnRH neuronal development in this condition.  
Objective: Examine the functional role a novel structural defect affecting a long 
noncoding RNA (lncRNA), RMST, found in a KS patient.  
Design: Whole genome sequencing (WGS), induced pluripotent stem cells (IPSC) and 
derived neural crest cells (NCC) from the KS patient were contrasted with controls. 
Setting: The Harvard Reproductive Sciences Center, MGH Center for Genomic Medicine 
and Singapore Genome Institute.  
Patient: A KS patient with a unique translocation, t(7;12)(q22;q24).  
Interventions/Main Outcome Measure/ Results: A novel translocation was detected 
affecting the lncRNA, RMST, on chromosome 12 in the absence of any other KS 
mutations. Compared to controls, the patient’s iPSC and NCC provided functional 
information regarding RMST. Whereas RMST expression increased during NCC 
differentiation in controls, it was substantially reduced in the KS patient’s NCC co-incident 
with abrogated NCC morphological development and abnormal expression of several 
‘downstream’ genes essential for GnRH ontogeny (SOX2, PAX3, CHD7, TUBB3 & 
MKRN3). Additionally, an intronic SNP in RMST was significantly implicated in a GWAS 
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Conclusions: A novel deletion in RMST implicates the loss of function of a lncRNA as a 
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The hypothalamic peptide, Gonadotropin Releasing Hormone (GnRH), is a prime mover 
of sexual maturation in mammals [1]. Human genetics has identified mutations in several 
genes that cause Isolated GnRH deficiency (IGD), a rare Mendelian disorder [2] 
manifested by abnormal puberty, hypogonadotropism and infertility [2]. Kallmann 
Syndrome (KS) is a phenotypic subset of IGD defined by the association of IGD with 
anosmia. Discoveries of nearly 20 mutated genes in KS patients have begun to define an 
emerging genetic architecture governing GnRH neuronal development 
[3-8].  
Following early fate specification as GnRH cells, GnRH precursor cells co-migrate with 
their olfactory companions into the CNS apparently utilizing common guidance 
mechanism(s) shared with olfactory axons. These still-maturing GnRH neurons permeate 
the porous cribriform plate guided via as yet unknown genes on the journey to their final 
hypothalamic destination from which they oversee the control of the reproductive axis in 
all mammals [9, 10].  During these complex developmental processes, GnRH neurons 
mature and expand their numbers, eventually giving rise to a population of ~10,000 
functioning GnRH neurons in the hypothalamus that ultimately govern human 
reproduction [3, 10].  
Critical biological clues regarding the genetic components that control these basic 
developmental processes have been provided by the discovery of several distinct 
structural genomic variations in KS patients.  An Xp22.3 contiguous gene syndrome 
established anosmia 1- ANOS1 (previously known as Kallmann 1- KAL1) as the first KS 
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identified fibroblast growth factor receptor 1- FGFR1 as the first autosomal dominant KS 
gene [15]. Similarly, balanced chromosomal rearrangements on chr10 and chr12 
identified WD Repeat Domain 11- WDR11 as a cause of KS [16] and a heterozygous 
deletion revealed semaphoring 1- SEMA3A as another causal KS gene [17].  The 
studying such informative structural events has been particularly limited by their rarity and 
the utilization of traditional human genetic methodologies.  
 
We have used next generation sequencing (NGS) in a KS patient previously reported to 
harbor a “balanced” t(7;12) chromosomal translocation.  NGS can resolve structural 
defects to the single base pair level and thus reveal ever subtler defects in unknown 
disease-causing genes [18-20].  Using NGS, we revealed a previously unrecognized 
breakage on Ch12 that disrupted RMST, a gene not previously linked to IGD. RMST is a 
lncRNA that has been previously shown to regulate neurogenesis through its direct 
binding to the transcription factor Sox2 [21]. To assess if the identified defect in RMST in 
our patient contributes to KS, we performed functional studies using NCC generated from 
healthy control and patient-derived iPSC. These studies demonstrate novel 
developmental impacts associated with the loss of function of RMST in GnRH neuronal 
and NCC development.  
Materials and Methods 
Long insert whole genome sequencing (LiWGS) was performed on the KS patient’s cell 
lines/DNA samples that were obtained from the NIGMS Human Genetic Cell Repository 
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balanced de novo translocation t(7;12)(q22;q24) [20, 22, 23] as previously described [19, 
24-28] (Figure 1) that were validated by Sanger sequencing. 
Whole Exome Sequencing (WES) was performed on the Broad Institute’s Sequencing 
Platform and rare sequence variants (RSVs) in the 35 known IGD genes were sought 
(Table S1[29]).  
Targeted Sequencing of potential RMST disruption in IGD Cohort: The RMST locus on 
chromosome 12 was captured end to end (introns and exons included) from hg19/b37 
genomic coordinates 12:97856799 to 97929544 using the Roche Nimblegen SeqCap 
Easy Probe kit requiring that >95% of the RMST locus target bases be covered at least 
10X.  
Copy number variations (CNVs): A cohort of IGD samples were sequenced for CNVs 
using the iPsychCNV pipeline [30] from a cohort of 1,386 patients with genotypes from 
the Illumina PsychChip SNP array [31] and annotated against genecode_v19 [32].  
Generation of pluripotent stem cells from proband/controls and differentiation of KS and 
wild-type iPSCs into neural crest cells (NCC): To test RMST expression in neural crest 
cells, the previously published stepwise differentiation of human pluripotent stem cells 
(hPSCs) to multipotent NC cells was used [33]. The resulting iPSCs were then treated for 
11 days with the Wnt agonist (CHIR99021) under dual-SMAD inhibition for the first 4 days 
[34].  Efficiency of NCC induction was monitored based on SOX10 immunostaining, which 
marks early multipotent NC stem cells.  
RMST expression in iPSCs and NCCs:  Expression of RMST and all genes presented in 








/dgz011/5601163 by London School of H
ygiene & Tropical M













SOX10 RNA-immunoprecipitation (RIP) (Day 21 NCC lysates): RIP was performed as 
described [21] on Day 11 NCs cells harvested in RIP buffer. Cells lysates were pre-
cleared with Protein G magnetic beads before incubating with specific antibodies against 
SOX10 or an IgG control. For each assay, 5 mg of antibodies was used, incubated with 
pre-cleared lysate at RT for 4 hours, and incubated with protein G magnetic beads for 2 
hours. The resulting bound proteins were washed X3 in RIP buffer and eluted in Trizol 
reagent for RNA extraction. 
ChIP-Seq Analysis: Chip- Seq analysis was performed to identify SOX2 binding sites in 
human neural stem cell lines as previously described [21]. In brief, redundant reads that 
could result from the over-amplification of ChIP DNA were removed and peak enrichment 
then calculated relative to the genome background. A threshold of p = 10-5 was used to 
call significant peaks. An ‘‘input’’ sample was also included to eliminate nonrandom 
enrichment [35]. To filter for high-confidence ChIP-seq peaks, the difference between the 
SOX2 libraries and input mapped reads were plotted vs. random SOX2 peaks. Peaks 
with a greater peak height in comparison to random peaks were then selected. For motif 
discovery, the HOMER 4.1 algorithm [36] was applied to each set of ChIP-seq libraries 
for de novo binding motif discovery and known motif analysis with default parameters. All 
significant peaks were used for motif analysis in both sets of SOX2 ChIP-seq 
experiments. The HOMER 4.1 software annotated the peaks using the hg18 genome 
assembly RefSeq genes transcription start site (defined from -1 kb to +100 bp), 
transcription termination site (by default defined from -100 bp to +1 kb), exons, 50 UTR, 
30 UTR, introns, and intergenic regions. 
Statistical analysis: All assays were performed in 3 independent experiments (biological 
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the manuscript, * denotes p < 0.05, ** denotes p < 0.01 and *** denotes p < 0.001.  To 
test for excess of rare variants, IGD cases were compared to control cohorts we utilized 
the gnomAD database[37] using Fisher's exact test. P < .05 was considered significant. 
Study approval: Approval from the tribal and Indian Health Service IRB and the MGH 
IRBs were obtained. 
Results: 
A Kallmann Syndrome patient with a de novo chromosomal translocation 
A Native American (Chippewa/French) man diagnosed with Kallmann Syndrome (KS) 
presented at age 22 with a prepubertal status, hypogonadotropism and anosmia, unfused 
epiphyses, shortened metacarpals with clubbed distal ends, a sharply outlined occipital 
region, and delayed mental development confirmed by formal testing [20, 22, 23]. He 
never underwent treatment for his hypogonadism. By age 44, he had developed 
hypertension and Type II Diabetes.  He was 175 cm tall, weighed 89.5 kg, had a span of 
156 cm (difficult with prior orthopedic surgeries implying skeletal dysplasia) and an 
upper/lower segment ratio of 0.68. He remained undervirilized with no axillary and sparse 
pubic hair. His penis was underdeveloped and testes were prepubertal at <4ml. He had 
no neurologic deficits.  He was the oldest of 6 full siblings (5 female and 1 male) and 3 
half siblings (2 male and 1 female), all without evidence of KS or other reproductive or 
skeletal disorders. Laboratory confirmed hypogonadotropic hypogonadism and a 
pyelogram showed two normal kidneys. His initial karyotype revealed a reciprocal 
translocation (7;12)(q22;q24) that was absent in both parents and an additional, 
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Precise mapping of chromosomal breakpoints. 
 No genes previously associated with KS mapped to the breakpoints on Ch7 and Ch12 
that were observed in this patient.  Therefore, we used NGS to more accurately determine 
the genetic variations of this patient. Applying long insert whole genome sequencing 
(LiWGS) (cf. Methods &. Figure 1) we precisely determined the genomic breakpoints at 
t(7;12)(q21.13,q23.1).  This sequencing  revealed a 2 bp deletion on Chr12 that disrupted 
intron 2 of the longest transcript of a previously identified lncRNA [AK056164 (2.5 kb); 
chr12:97,860,651-97,860,653] of the Rhabdomyosarcoma 2 Associated Transcript 
(OMIM#607045)], RMST. The disruption led the gene to span into two different 
chromosomes, implying the complete disruption of this lncRNA and/or separation of the 
second piece of gene from its regulatory region. The other breakpoint on Ch7 did not 
disrupt any annotated gene [43]. Neither breakpoint spans known DNase I 
hypersensitivity sites nor disrupts any open reading frames of RMST. The Database of 
Genomic Variants revealed few duplications spanning this region and extremely rare 
microdeletions were reported by the 1,000 Genome Project [44].  Additional searches of 
~13,991 controls [19] confirmed the absence of any copy number variations (CNVs) 
spanning this region.  
 
We next performed whole exome sequencing (WES) of the proband to identify any coding 
variants.  WES revealed a rare missense variant in the gene of leptin receptor ,LEPR:  
p.V658I predicted to be benign by Polyphen [45] and SiFT [46] with a minor allele 
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subpopulation.  No loss-of-function (LoF) rare sequencing variants (RSVs) in any of the 
35 known isolated GnRH deficiency (IGD) genes existed (cf. Table S1[29]). Thus, the 
unique de novo disruption in RMST was the only genetic abnormality evident by LiWGS 
and WES in the genome of this KS patient.  
 
Sequencing the RMST locus in additional  IGD patients  
Given the finding of a novel RMST breakage in the proband, we searched for RMST 
genetic variations in a cohort of 622 IGD individuals (292 KS and 330 nIHH).  For each 
patient DNA sample, the RMST locus was captured with primers and sequenced with at 
least 10X coverage. A total of 17 RSVs in RMST were detected (13 KS and 18 nIHH), all 
of which were unique or had a MAF frequency <1% [37] (Table 1).  One KS patient carried 
3 RSVs in RMST.  No rare non-coding exonic homozygous RSVs in RMST exist in 
GnomAD.  Ethnicity-based burden testing was performed to test for statistical excess of 
RSVs in IGD probands vs. ethnically matched controls (Table 2). An excess of such RSVs 
was seen in Caucasian/non-Finish Europeans and African Americans control cohorts 
whereas Asian IGD patients showed a non-significant excess compared to Asian controls 
[47]. No other structural variants (CNVs) at the RMST site of any others were found in 
1,386 IGD probands. 
 
RMST expression in cell-based models of neural crest cell development  
RMST is highly expressed in the murine hypothalamus, at lower levels in whole brain, 
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producing cell lines (data not shown). RMST expression has previously been 
demonstrated to be critical for neuronal development [21]. Hence, its role in the 
development of specific subsets of neurons derived from neural crest cells (i.e. those 
presumably contributing to GnRH neurogenesis) was examined.  To address this issue, 
an in vitro model of NCC development was developed to begin to define RMST’s role in 
neurogenesis in the patient vs control (N=6) cell lines.  
Using episomal reprogramming vectors, patient-specific, induced pluripotent stem cells 
(iPSC) were generated from lymphoblastoid cells derived from the proband. These 
patient-derived iPSC (KS1-iPSC) were confirmed to be pluripotent by expression of Oct4, 
Nanog, Sox2, and Tra1-81 (pluripotency markers) and their ability to generate all 3 germ 
layers by in vitro differentiation (Figure S1A & S1B[29]). The presence of t(7;12) 
chromosomal translocation was confirmed in KS1-iPSC by PCR amplification (Figure 
S1C[29]) and DNA sequencing (data not shown); the RMST breakpoints were identical 
to those of the patient’s DNA. Neural crest cells (NCC) were subsequently derived from 
the KS1-iPSC and healthy control iPSC (CTS-iPSC) by directed differentiation using 
established protocols involving the inhibition of BMP, TGF-β, and WNT signaling 
pathways. Differentiation was assessed by expression of Sox10, a marker of early, 
multipotent NC stem cells.   
While RMST expression was detected in both the KS1-iPSC and healthy CTS- iPSCs, 
the KS1-iPSCs had significantly decreased expression of all RMST transcripts (~6%-18% 
vs. healthy iPSCs; p < 0.0018) (Figure 2). During NCC development, RMST transcripts 
increased for control iPSCs as differentiation progressed coincident with the appearance 
of known neural crest markers, p75NGFR and AP2a (Figure S2[29]). In contrast, RMST 
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showed significant reductions in all isoforms of RMST (AK056164, AF429305 and 
AF429306) that were <10% of healthy NCC (p < 0.0001) (Figure 3A) confirming reduced 
RMST expression in the patient’s iPSC and NCC.  
 
 
RMST binds to SOX10 in iPSC-derived neural crest cells  
RMST has been shown to interact directly with SOX2 during neurogenesis. Therefore, 
we explored whether RMST interacts directly with SOX10. Sox10-specific antibodies 
were used in RNA immunoprecipitation (RIP) experiments in NCC derived in vitro from 
iPSC. Robust enrichment of RMST was observed in SOX10 RIP (Figure 4). As both 
RMST and SOX2 are essential for neuronal development, it is plausible that RMST-
SOX10 interactions are similarly critical for NCC differentiation. To confirm that RMST 
interactions with SOX10 and SOX2 are similar, both KS and healthy iPSCs were exposed 
to NCC differentiation conditions and the SOX10-expression in NCC cells quantified. The 
efficiency of NCC differentiation in healthy iPSCs was 10% vs only 2% of the KS1 iPSCs 
that became SOX10+ NCC cells (cf. Figure 5). 
 
Evidence of Direct RMST-SOX2 Interactions: Using Chip-Seq analysis [21] and siRNA 
depletion of RMST in neuronal stem cells, SOX2 binding sites were assessed at 35 known 
IGD genes. Of the 15 IGD genes containing a SOX2 binding site (Table 3), RMST deletion 
induced loss of occupancies in 12/15, several of which are known major and/or candidate 
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RNF216, OTUD4, FEZF1, MKRN3, IL17RD) and DUSP6.  Intriguingly, SOX2 binding 
sites on TACR3, TUBB3 and FLRT3 were not altered upon deletion of RMST and, in 
PROKR2, a novel SOX2 binding site was acquired upon RMST depletion. 
 
Effect of RMST LoF on downstream target genes: Previous depletion of RMST by 
siRNA in neural stem cell lines decreased the levels of the known IGD- associated genes 
CHD7, TUBB3 & SEMA3A and increased MKRN3 [21]. To determine these effects of our 
patient’s RMST depletion on these same IGD genes, their levels were measured in the 
KS1 and control NCC on Days 11 and 21 of differentiation (Figure 3A).  At Day 11, KS1 
cells expressed reduced levels of SOX2, TUBB3 & CHD7 but no change in SOX10 and 
SEMA3A. However, by Day 21, a 2.4-fold increase in SEMA3A and 2-fold increase in 
MKRN3 expression levels had become evident (Figure 3B). 
 
Discussion  
LiWGS in a KS patient with a known de novo chromosomal rearrangement identified a 
novel disruption in the lncRNA, RMST. RMST’s association with neuronal development 
is based on its strong, early neuronal localization and expression in the Wnt and 
TGFβ/BMP rich domains of the embryonic dorsal forebrain [48]. In addition, RMST 
expression increases during critical stages of neuronal differentiation [49, 50] when it 
binds directly to SOX2 (23,61), a critical transcriptional regulator of GnRH ontogeny. 
RMST knock-downs in neuronal stem cells also reduce expression of CHD7, SEMA3, 
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in general and RMST specifically remain largely unclear in part due to the lack of any 
functional assay to assess their loss of function. Thus, to address the potential role of 
RMST depletion in our KS patient, we generated iPSC and NCC from this unique KS 
patient with a translocation-disrupting deletion in RMST.  
RMST expression increases during normal neuronal differentiation and binds directly to 
and potentially amplifies SOX2 and likely SOX10’s effects on early GnRH neuronal 
development. In contrast, in the presence of this translocation, RMST expression was 
significantly lower compared to healthy iPSC cells and the NCC development was 
severely disrupted. A large number of IGD-causing genes, particularly ones already 
identified to be SOX2-dependent and hence play a critical role in NCC development (e.g. 
CHD7 and TUBB3), failed to develop in the RMST-deficient iPSC and NCC cells.  
We hypothesize that RMST plays an essential role as a co-factor for SOX2 (and 
presumably SOX10) in GnRH neuronal differentiation by binding to the promoter regions 
of several important neurogenic genes. These include many known IGD-causing genes 
(FGFR1, TAC3, NROB1, LEPR, SOX10, RNF216, OTUD4, FEZF1, MKRN3, MCM4, 
IL17RD and DUSP6). RMST also shares binding with SOX2 to the promoters of the same 
neurogenic transcription factor genes such as Neurogenin 2, underscoring its partnership 
with SOX2.   
SOX2 has a known role in the early development of the hypothalamic-pituitary-gonadal 
axis and differentiation of GnRH neurons in addition among other neurogenic progenitors 
during development of olfactory and vomeronasal receptors [54].  Patients with 
heterozygous mutations in SOX2 exhibit IGD with or without ocular defects [55]. Thus, 
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downstream SOX2–dependent (and now ‘RMST-dependent’) genes critical for GnRH 
neuronal differentiation as validated by the fact that most of these genes also cause KS 
when mutated [17, 21, 52, 53, 56].  
RMST depletion led to initial decreases on Day 11 followed by further increases on Day 
21 relative to controls in MKRN3, a paternally imprinted gene in the Prader-
Willi/Angelman critical region whose LoF mutations are associated with precocious 
puberty (CPP) [57]. Mkrn3 is highly expressed in the arcuate nucleus of the hypothalamus 
during the infantile and early juvenile periods with subsequent reductions at postnatal 
days 12-15, i.e. just prior to GnRH-induced sexual maturation in mice [57, 58]. 
Collectively, these observations suggest that MKRN3 plays a ‘braking’ function in the pre-
pubertal inhibition of GnRH secretion and that any sustained increase in its expression 
could lead to a potentially severe delay of pubertal development such as occurs in KS 
and IGD.   
These associative data demonstrate for the first time that RMST is a lncRNA implicated 
in GnRH deficiency and has a key role as a co-governor with SOX2 in regulating 
downstream KS genes, making it the potential cause of the KS phenotypic expression in 
our subject. It remains to be seen if other structural or genetic abnormalities in RMST 
and/or other non-coding genes in this domain (or others) can also cause KS. Future 
mammalian modeling e.g. RMST knock-outs will hopefully provide more detailed 
mechanistic and developmental insights into the mechanisms by which RMST governs 
GnRH neurogenesis. The previous inherent difficulties of examining functional 
consequence of alterations in non-coding regions has been a formidable generic limitation 
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IPSC and NCC cells begins to address these biological limitations in a convincing way, 
at least as RMST relates to neurogenesis and the ontogeny of GnRH neurons.  
Even though rare RMST variants were discovered in both KS and nIHH patients, rare 
variants were also found in excess in control population. Given the non- coding nature of 
the gene, the functional effect of these point variants can be difficult to be examined. The 
rarity of KS (1:30,000 in men; 1:125,000 in women) [59], challenges efforts to seek 
replication of these findings in other humans. Importantly, no CNVs were detected in IGD 
cohort of 1,386 probands and no CNVs were detected in a large cohort of controls either 
(N=13,991), highlighting the rarity of occurrence of structural events in this genomic 
region. Similarly, structural defects causing human disease are rare but quite critical in 
revealing novel biological roles in such areas as autism. Thus, given the large body of 
coherent biologic evidence from these current studies, we believe these observations 
from this single KS patient lacking any other cause of his disease by WGS are coherent 
and call attention to a novel role of a LncRNA, RMST, as a genomic region worthy of 
further study.  Future accurate WGS will continue to resolve ever smaller potential defects 
in other coding and non-coding genomic regions in important human disease models like 
IGD with relevance to developmental biology and pathophysiology. 
The complexity of analyzing the genetic changes in noncoding areas led to identification 
of additional studies that implicated RMST to pubertal regulation. An association between 
the SNP rs76369685 located in the second intron of RMST and the age of menarche in 
the UK Biobank was detected [60]. The same SNP was also associated with gestational 
and type 1 diabetes in databases of 102,000 and 146,000 individuals (data not shown). 
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can explain the lack of enrichment of exonic RMST genetic changes in the IGD cohort 
compared to controls.  
In conclusion, RMST’s high expression during normal neural crest cell differentiation, its 
direct association with key neural transcription factors, SOX2 and SOX10, its ability to 
regulate downstream genes that control the reproductive axis such as CHD7, TUBB3 and 
MKRN3 and its association with the age of menarche all support a previously 
unappreciated role for RMST as a regulator of neural crest development potentially  
affecting GnRH precursors. 
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Table 1: Rare sequencing variants (RSVs) in RMST.  
Table 1 shows all the rare sequencing variants (RSVs) (defined as variants with allele 
frequenting <0.1% the gnomAD database) including their: chromosomal position, nucleic 
acid change, annotations (only the splice region changes have been annotated), exonal 
position, diagnosis of the affected proband, RSVs in other IGD genes. Note that all RSVs 
were found to be in heterozygous state. 
 
Table 2: Burden testing in IGD vs. gnomAD cohort 
 
Legend: Table 2 shows the prevalence of rare variation (MAF<1%) and very rare 
variation (MAF <0.1%) in the IGD cohort and the reference- control database of the 
gnomAD. The statistical differences were calculated between cohort of similar genetic 
background. MAF: minor allele frequency; N/A: not available.  
 
Table 3: SOX2 binding sites in known IGD genes and changes after depletion of RMST. 
 
Table 3 shows the SOX2 binding sites of the known IGD genes. From the 35 known 
IGD genes, 15 contain a SOX2 binding site. Upon deletion of RMST the SOX2 binding 
sites disappear in 12 out of 15 genes including FGFR1, TAC3, NROB1, LEPR, SOX10, 
RNF216, OTUD4, FEZF1, MKRN3, MCM4, IL17RD and DUSP6. On the other hand, 
SOX2 binding sites of TACR3, TUBB3 and FLRT3 were not altered upon deletion of 
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Figure 1: Base pair resolution of the “balanced” chromosomal rearrangement 
demonstrates a breakpoint to be in RMST. 
Figure 2: RMST levels in both the KS patient’s IPSC (KS1) & healthy control’s iPSCs; 
the patient’s iPSCs expressed only 6%-18% of the total RMST transcripts (AK056164, 
AF429305 and AF429306) that were expressed by healthy iPSCs but with no significant 
differences in SOX2 and SOX10  expression in both cell lines. 
Figure 3 A&B: Expression of SOX2, SOX10, RMST transcripts (AK056164, AF429305 
& AF429306), PAX3, GNRH1, TFAP2A, CHD7, SEMA3A, MKRN3 and TUBB3 in 
patient’s neural crest cells compared to controls after induction of NC differentiation for 
Days 11 and 21. KS1: patient’s cells and CTS: control’s cells. 
Figure 4: Interaction of RMST transcripts AK056164 and AF429305 with SOX2 and 
SOX10: RNA-immunoprecipitation was performed with isotype IgG as negative control 
and SOX2 as positive control. Significant enrichment of RMST transcripts AK056164 and 
AF429305 in SOX10 pulldown samples indicated interaction between SOX10 and RMST. 
Figure 5: RMST transcript quantification was repeated again on Day 11 of differentiation, 
when the iPSCs have differentiated into neural crest cells (NCS). Patient NC cells 
expressed <20% of the RMST transcripts present in healthy NC. KS1: patient’s cells and 
CTS: control’s cells. 
Abbreviations: IGD- Isolated GnRH Deficiency, KS: Kallmann Syndrome, LiWGS: Long 
Insert Whole Genome Sequencing, NGS: Next Generation Sequencing, LncRNA: Long-
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Table 1 
Chr bp Ref Alt Annotation Location Dx Gender Other genes Zygosity gnomAD 
12 97858842 A G   Exon 1 KS male 
KLB c.820A>G p.I274V 
het; FGFR1 c.1097C>T 
p.P366L het het 
3.23E-05 
12 97858843 T C   Exon 1 nIHH male   het not seen 
12 97885730 G A   
Exon 1 
of 
MIR1251 KS male   hom not seen 
12 97887656 T A   Exon 5 KS male 
KAL1 c.1759G>T 
p.V587L hem het 3.23E-05 
12 97887663 G A n.256-6G>A Exon 5 nIHH male   het 0.000226 
12 97887706 T A   Exon 5 nIHH male   het not seen 
12 97887763 G A   Exon 5 KS male   het 3.23E-05 
12 97888490 C T   Exon 6 
KS male   
het 0.00097 
12 97888657 A G n.1521A>G Exon 6 het 0.000807 
12 97927340 T C   Exon 9 het 0.000486 
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12 97926848 C T   Exon  9 KS male 
PROKR2 c.254G>A 
p.R85H het; het 0.000388 
12 97926848 C G   Exon  9 KS male   het not seen 
12 97962885 G A   Exon 9 nIHH female 
IL17RD c.1697C>T 
p.P566L het;  het not seen 
            nIHH male   het   
            KS male 
OTUD4 c.755T>C 
p.V252A het;  het   
            nIHH male 
CHD7 c.2831G>A 
p.R944H het; PROKR2 
c.991G>A p.V331M 
het; FGFR1 c.289G>A 
p.G97S het  het   
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            KS male 
KLB c.1825A>G 
p.T609A het het   
            nIHH female 
NR0B1 c.376G>A 
p.V126M het; PROK2 
c.218G>A p.R73H het het   
            nIHH male 
CHD7 c.120A>C 
p.Q40H het; CHD7 
c.4565A>T p.D1522V 
het; PROKR2 c.949G>C 
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p.L2806V het;  het 0.000259 
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Chr bp Ref Alt Annotation Location Daignosis Gender
12 97858842 A G Exon 1 KS male
12 97858843 T C Exon 1 nIHH male
12 97886308 G C Exon 3 KS male
KS female
12 97887656 T A Exon 5 KS male
12 97887663 G A n.256-6G>A Exon 5 nIHH male
12 97887706 T A Exon 5 niHH male
12 97887763 G A Exon 5 KS male
12 97888490 C T Exon 6
12 97888657 A G n.1521A>G Exon 6
12 97927340 T C Exon 9
12 97889772 C A Exon 7 KS male
12 97926773 G T Exon 9 nIHH male
nIHH male
12 97926848 C T Exon  9 KS male
12 97926848 C G Exon  9 KS male
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nIHH male
12 97927223 C T Exon 9 KS male
nIHH male
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KLB c.820A>G p.I274V het; FGFR1 





















Flat fett and eye 
defects
GLCE c.427G>A p.V143M het; POLR3B 
c.1-1C>T het; CHD7 c.7315G>A 




spectum & high 
arched palate





CL/CP IL17RD c.1697C>T p.P566L het; African American
No Not assessed
Flat feet & pectus 
exvacatum
OTUD4 c.755T>C p.V252A het; Asian
No
CHD7 c.2831G>A p.R944H het; 
PROKR2 c.991G>A p.V331M het; 
FGFR1 c.289G>A p.G97S het; 
Asan
Ataxia Not assessed
Synkinesia KLB c.1825A>G p.T609A het; Asian
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Crowded teeth & 
protruding ears
CHD7 c.120A>C p.Q40H het; CHD7 
c.4565A>T p.D1522V het; PROKR2 











No TACR3 c.623G>A p.W208X het; Caucasian
Curved spine, 
foreshortened 
arm/leg & bone 
deformities
CHD7 c.5051-4C>T het; LEPR 
c.2246T>C p.L749S het; FGFR1 




GNRHR c.892_893insA p.N298KfsX22 
hom; KISS1R c.998C>T p.A333V het;
Caucasian
No
IL17RD c.2012C>T p.S671L het; 





CHD7 c.2819C>T p.P940L het; also 
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0.0002665 (Non Finish Europeans); 0.0002862 (Finish 
Europeans)
None
















/dgz011/5601163 by London School of H
ygiene & Tropical M
edicine user on 21 O
ctober 2019
0.0003339 (Non Finish European); 0.0002862 (Finish 
Europeans); 0.001196 (Latino);  0.001018 (Other)
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